The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.

The average ADHD medication treatment for children exceeds three years while safety data only covers one year. Boys starting ...

With school counselors outnumbered and mental health workers overloaded, can AI chatbots help students with immediate needs ...

Members of the Neu Narrative support group say they, or their children, have waited years for a diagnosis and have been ...

Like many adult women struggling to find answers in the medical system, Kristen Einarson was first “diagnosed” with ADHD, or ...

Parenting a child with Attention Deficit Hyperactivity Disorder (ADHD) can be incredibly challenging. The endless demands, coupled with the unpredictable nature of the disorder, can create a chaotic ...

A Tasmanian teenager who held up a liquor store with a 20-centimetre knife has avoided jail, in what a judge described as a ...

A professional psychiatrist has revealed the telltale signs he frequently observes in women living with Attention Deficit ...

Open-access publication demonstrates the validity and reliability of the Mentavi online Diagnostic Evaluation compared to a clinical interview, widening evidence based telehealth access for adults ...

I remember I just walked into work and burst into tears… I said: ‘I can't physically afford to live anymore.’” “At that point ...

KEGE Center for ADHD, a psychiatric practice dedicated to evidence-based ADHD care, has expanded and enhanced its core services to better serve patients across Arizona. These improvements aim to ...

Caring for someone often means experiencing challenges that may not be visible to others. For caregivers, public outings can ...